Back to 
Egerton Capital (UK) LLP
Egerton Capital (UK) LLP
ELV
Showing 0 of 2 quarters
Position history for Egerton Capital (UK) LLP's holdings in Elevance Health, Inc.
No. Egerton Capital (UK) exited its ELV (Elevance Health) position in Q2 2019. Its Q1 2019 13F listed 694,185 shares worth $199.2M. Egerton Capital (UK) already held ELV in its Q1 2019 13F, the earliest on record, and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.